-
Multiple Ras functions can contribute to mammalian cell transformation.
Cell. 1995 Feb 24;80(4):533-41
PMID: 7867061
-
Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta.
J Biol Chem. 1994 Dec 16;269(50):31706-10
PMID: 7989344
-
A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways.
Mol Cell Biol. 1995 Jun;15(6):3238-46
PMID: 7760819
-
Overexpression of mammalian protein kinase C-zeta does not affect the growth characteristics of NIH 3T3 cells.
Biochem Biophys Res Commun. 1995 Aug 4;213(1):266-72
PMID: 7639744
-
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Mol Cell Biol. 1996 Jul;16(7):3923-33
PMID: 8668210
-
Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.
FEBS Lett. 1996 Aug 26;392(2):77-80
PMID: 8772178
-
Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.
Mol Cell Biol. 1997 Jul;17(7):3547-55
PMID: 9199290
-
MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases.
J Biol Chem. 1997 Dec 19;272(51):32056-60
PMID: 9405400
-
A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis.
J Biol Chem. 1998 Jul 10;273(28):17696-701
PMID: 9651367
-
The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation.
J Cell Biol. 1998 Jul 13;142(1):241-50
PMID: 9660877
-
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta.
EMBO J. 1998 Jul 15;17(14):4046-55
PMID: 9670019
-
The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation.
Biochem J. 1998 Aug 1;333 ( Pt 3):631-6
PMID: 9677322
-
Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins.
Mol Cell Biol. 1998 Oct;18(10):5780-7
PMID: 9742095
-
Increasing complexity of Ras signaling.
Oncogene. 1998 Sep 17;17(11 Reviews):1395-413
PMID: 9779987
-
Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.
Biochem J. 1999 Feb 1;337 ( Pt 3):461-70
PMID: 9895289
-
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton.
J Cell Biol. 1999 Feb 8;144(3):413-25
PMID: 9971737
-
Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling.
J Biol Chem. 1999 Jul 2;274(27):19025-34
PMID: 10383403
-
Loss of FGF receptor 1 signaling reduces skeletal muscle mass and disrupts myofiber organization in the developing limb.
Dev Biol. 2000 Feb 1;218(1):21-37
PMID: 10644408
-
ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
J Cell Physiol. 2001 Jan;186(1):104-15
PMID: 11147804
-
Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells.
J Cell Biol. 2001 Mar 19;152(6):1301-5
PMID: 11257129
-
Differential effects of Ras signaling through NFkappaB on skeletal myogenesis.
Oncogene. 2001 Mar 15;20(11):1276-86
PMID: 11313872
-
Control of mouse myoblast commitment to terminal differentiation by mitogens.
J Supramol Struct. 1980;14(4):483-98
PMID: 6454029
-
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J. 1986 Dec 1;5(12):3133-42
PMID: 3102226
-
The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
Mol Cell Biol. 1987 Jun;7(6):2104-11
PMID: 3600660
-
Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.
J Cell Biol. 1987 Aug;105(2):949-56
PMID: 3624313
-
Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
Oncogene. 1989 Apr;4(4):473-81
PMID: 2654809
-
Retention of specific protein kinase C isozymes following chronic phorbol ester treatment in BC3H-1 myocytes.
Biochem Biophys Res Commun. 1989 May 30;161(1):327-34
PMID: 2730662
-
Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
Cancer Res. 1989 Nov 15;49(22):6324-7
PMID: 2680062
-
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
J Biol Chem. 1991 Aug 25;266(24):15771-81
PMID: 1874734
-
Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes.
Mol Cell Biol. 1992 Sep;12(9):3776-83
PMID: 1508183
-
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.
Science. 1992 Oct 23;258(5082):607-14
PMID: 1411571
-
Protein kinase C zeta isoform is critical for mitogenic signal transduction.
Cell. 1993 Aug 13;74(3):555-63
PMID: 7688666
-
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
J Cell Biol. 1994 Jun;125(6):1275-87
PMID: 8207057
-
Protein kinase C and lipid signaling for sustained cellular responses.
FASEB J. 1995 Apr;9(7):484-96
PMID: 7737456